Skip to main content
. 2020 Jun 11;4(4):379–385. doi: 10.1002/ags3.12349

Table 1.

Various total neoadjuvant treatment protocols in the review article

Author Study design Treatment group Primary outcome

Marco et al 25

Nonrandomized

Group I: neoadjuvant LCRT

Group II: Neoadjuvant LCRT – Consolidation CTx 2cycles

Group III: Neoadjuvant LCRT – Consolidation CTx 4cycles

Group IV: Neoadjuvant LCRT – Consolidation CTx 6cycles

pCR rate

Surgical difficulty

Postoperative complication

Bujko et al 26

Randomized

neoadjuvant LCRT

vs. Conolidation CTx following SCRT

R0 resection

RAPIDO trial 27

Randomized

neoadjuvant LCRT

vs. Conolidation CTx following SCRT

DFS after 3 years
Fernandez‐Martos et al 32 Nonrandomized

neoadjuvant LCRT

vs. Induction CTx followed by LCRT

pCR rate
Cercek et al 33 Retrospective

neoadjuvant LCRT

vs. Induction CTx followed by LCRT

pCR rate

Group I:21%, group II:36%

CAO/ARO/AIO‐12 trial 35 Randomized

Induction CTx followed by LCRT

vs. Conolidation CTx following SCRT

pCR rate
PROSPECT trial 30 Randomized

neoadjuvant LCRT

vs. induction CTx with or without RTx

R0 resection

DFS after 3 years

Abbreviations: CTx, chemotherapy; DFS, disease free survival, RTx, radiotherapy; LCRT, long‐course chemoradiation therapy; pCR, pathologic complete response; SCRT, short‐course chemoradiation therapy.